Medius Holdings Co., Ltd. (3154) AI Stock Analysis

• Market Cap: ¥18.48B
• Dividend Yield: 2.43%
• Average Volume (3M): 18.86K
• Price to Earnings (P/E): 13.4
• Beta (1Y): 0.60
• Revenue Growth: 11.12%
• EPS Growth: 20.58%
• Country: JP
• Employees: 2,517
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.19
• Shares Outstanding: 22,238,216
• 10 Day Avg. Volume: 27,380
• 30 Day Avg. Volume: 18,860
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥933.00
• Price Target Upside: 14.76% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 70 Outperform
• Price Target: ¥933.00 ▲(14.76% Upside)

Medius Holdings Co., Ltd. shows strong financial performance with revenue growth and profitability improvements, though increased leverage and cash flow volatility are concerns. The technical analysis indicates a bearish trend, but valuation metrics suggest the stock is reasonably priced with a decent dividend yield. These factors combine to give the stock a balanced score.

Medius Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and maintenance services for medical equipment to hospitals and other medical facilities. It is also involved in the sale and rental of nursing care and welfare equipment to hospitals, nursing care facilities, and general individuals; and sale and rental of on-board medical instruments for ambulance, AEDs, and other emergency supplies and equipment with high social needs. The company was formerly known as Kyowa Medical Holdings, Inc. and changed its name to Medius Holdings Co., Ltd. in October 2010. Medius Holdings Co., Ltd. was founded in 2009 and is based in Tokyo, Japan.

How the Company Makes Money

Medius Holdings Co., Ltd. generates revenue through the wholesale distribution of medical supplies and equipment to various healthcare providers and institutions. The company's key revenue streams include the sale of consumable medical products, surgical instruments, and diagnostic devices. Additionally, Medius Holdings may engage in partnerships with medical manufacturers to distribute exclusive products, enhancing its market presence and competitiveness. The company benefits from long-term contracts with hospitals and clinics, ensuring a steady income flow and fostering strong customer relationships. These factors, along with the growing demand for healthcare services, contribute significantly to the company's earnings.

Medius Holdings Co., Ltd. Financial Statement Overview

Summary

Medius Holdings Co., Ltd. demonstrates strong revenue growth and stable profitability margins. The balance sheet is solid with adequate leverage, though cash flow variations require attention.

Income Statement

Medius Holdings Co., Ltd. shows a strong revenue growth trajectory with recent TTM data indicating a rise in total revenue. The gross profit margin is stable, reflecting efficient cost management. However, the net profit margin has shown some volatility, which could be a concern. EBIT and EBITDA margins are consistent, suggesting operational stability.

Balance Sheet

The company's balance sheet reveals a moderate debt-to-equity ratio, indicating a balanced approach to leverage. The return on equity is healthy, demonstrating effective utilization of shareholder funds. The equity ratio is satisfactory, reflecting a solid asset base supported by equity.

Cash Flow

Cash flow analysis shows fluctuations in free cash flow, influenced by capital expenditure dynamics. Despite operating cash flow being zero in the latest TTM data, previous periods have shown positive cash flow generation. The company needs to focus on sustaining free cash flow for long-term stability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	286.18B	288.69B	259.79B	239.05B	221.69B	246.79B
Gross Profit	33.60B	33.30B	31.09B	29.31B	27.42B	25.20B
EBITDA	4.44B	4.77B	3.86B	4.27B	3.80B	4.14B
Net Income	1.35B	1.38B	1.12B	1.50B	1.87B	2.07B
Balance Sheet
Total Assets	123.52B	113.02B	114.83B	97.46B	92.95B	84.44B
Cash, Cash Equivalents and Short-Term Investments	16.13B	14.33B	13.66B	10.36B	9.15B	12.67B
Total Debt	24.26B	21.24B	24.17B	19.57B	17.82B	11.60B
Total Liabilities	102.87B	92.55B	95.09B	78.88B	75.65B	68.59B
Stockholders Equity	20.65B	20.48B	19.74B	18.57B	17.31B	15.84B
Cash Flow
Free Cash Flow	0.00	5.26B	261.12M	300.65M	-8.49B	2.93B
Operating Cash Flow	0.00	7.01B	1.92B	1.22B	-3.90B	6.85B
Investing Cash Flow	0.00	-2.51B	-2.67B	-862.94M	-4.82B	-4.62B
Financing Cash Flow	0.00	-3.47B	4.01B	862.90M	5.21B	1.90B

Medius Holdings Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 813.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Negative. The current price of 813 is below the 20-day moving average (MA) of 853.00, below the 50-day MA of 854.18, and below the 200-day MA of 883.33, indicating a bearish trend. The MACD of -5.59 indicates Positive momentum. The RSI at 39.68 is Neutral, neither overbought nor oversold. The STOCH value of 12.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3154.

Medius Holdings Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4556	81 Outperform	¥5.27B	8.53	―	2.50%	5.38%	-7.04%
7980	74 Outperform	¥5.62B	8.44	―	1.90%	5.45%	0.23%
3154	70 Outperform	¥18.48B	13.42	―	2.43%	11.12%	20.58%
7979	68 Neutral	¥68.76B	16.91	―	2.72%	6.82%	-1.08%
7743	67 Neutral	¥16.28B	14.61	―	2.79%	2.38%	-48.68%
7702	55 Neutral	¥10.65B	124.68	―	3.86%	3.36%	-310.49%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Medius Holdings Co., Ltd. Corporate Events

Medius Holdings Completes Logistics Division Reorganization

Medius Holdings Co., Ltd. has completed the internal reorganization of its logistics division by transferring it to a wholly owned subsidiary, now renamed Mediris Logistics Co., Ltd. This company split is expected to have an immaterial impact on the company’s overall business results, indicating a strategic move to streamline operations without disrupting financial performance.

Medius Holdings Reports Strong Q3 Financial Growth Amid Strategic Expansion

Medius Holdings Co., Ltd. reported significant financial growth for the third quarter ended March 31, 2025, with net sales increasing by 13.7% and operating profit rising by 22.6% compared to the previous year. The inclusion of two new companies in its consolidation scope reflects Medius Holdings’ strategic expansion, potentially enhancing its market position and offering improved services to stakeholders.